Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9570574rdf:typepubmed:Citationlld:pubmed
pubmed-article:9570574lifeskim:mentionsumls-concept:C1556094lld:lifeskim
pubmed-article:9570574lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:9570574lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:9570574lifeskim:mentionsumls-concept:C0009526lld:lifeskim
pubmed-article:9570574pubmed:issue3lld:pubmed
pubmed-article:9570574pubmed:dateCreated1998-5-14lld:pubmed
pubmed-article:9570574pubmed:abstractTextDeficiency of the ninth component of complement (C9D) is one of the most common genetic abnormalities in Japan, with an incidence of one homozygote in 1000. Although C9D individuals are usually healthy, it has been shown that they have an significantly increased risk of developing meningococcal meningitis. In the present study we report the molecular bases for C9D in 10 unrelated Japanese subjects. As a screening step for mutations, exons 2 to 11 of the C9 gene were analyzed using exon-specific PCR/single-strand conformation polymorphism analysis, which demonstrated aberrantly migrating DNA bands in exon 4 in all the C9D subjects. Subsequent direct sequencing of exon 4 of the C9D subjects revealed that eight of the 10 C9D subjects were homozygous for a C to T transition at nucleotide 343, the first nucleotide of the codon CGA for Arg95, leading to a TGA stop codon (R95X). R95X is a novel mutation different from those recently identified in a Swiss family with C9D. Cases 6 and 7 were heterozygous for the R95X mutation. Family study in case 10 confirmed the genetic nature of the defect. In case 6, the second mutation for C9D of the C9 gene was identified to be the substitution of Cys to Tyr at amino acid residue 507 (C507Y), while the genetic defect(s) in the other allele in case 7 remains unknown. Our results indicate that a novel mutation, R95X, is present in most cases of C9D in Japan.lld:pubmed
pubmed-article:9570574pubmed:languageenglld:pubmed
pubmed-article:9570574pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570574pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9570574pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570574pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570574pubmed:statusMEDLINElld:pubmed
pubmed-article:9570574pubmed:monthFeblld:pubmed
pubmed-article:9570574pubmed:issn0022-1767lld:pubmed
pubmed-article:9570574pubmed:authorpubmed-author:HayashiKKlld:pubmed
pubmed-article:9570574pubmed:authorpubmed-author:LaraF YFYlld:pubmed
pubmed-article:9570574pubmed:authorpubmed-author:SakaiKKlld:pubmed
pubmed-article:9570574pubmed:authorpubmed-author:KojimaTTlld:pubmed
pubmed-article:9570574pubmed:authorpubmed-author:HoriuchiTTlld:pubmed
pubmed-article:9570574pubmed:authorpubmed-author:InabaSSlld:pubmed
pubmed-article:9570574pubmed:authorpubmed-author:FukumoriYYlld:pubmed
pubmed-article:9570574pubmed:authorpubmed-author:HashimuraCClld:pubmed
pubmed-article:9570574pubmed:authorpubmed-author:SawabeTTlld:pubmed
pubmed-article:9570574pubmed:authorpubmed-author:SchneiderP...lld:pubmed
pubmed-article:9570574pubmed:authorpubmed-author:NishizakaHHlld:pubmed
pubmed-article:9570574pubmed:issnTypePrintlld:pubmed
pubmed-article:9570574pubmed:day1lld:pubmed
pubmed-article:9570574pubmed:volume160lld:pubmed
pubmed-article:9570574pubmed:ownerNLMlld:pubmed
pubmed-article:9570574pubmed:authorsCompleteYlld:pubmed
pubmed-article:9570574pubmed:pagination1509-13lld:pubmed
pubmed-article:9570574pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:meshHeadingpubmed-meshheading:9570574-...lld:pubmed
pubmed-article:9570574pubmed:year1998lld:pubmed
pubmed-article:9570574pubmed:articleTitleA non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese.lld:pubmed
pubmed-article:9570574pubmed:affiliationFirst Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan. horiuchi@intmed1.med.kyushu-u.ac.jplld:pubmed
pubmed-article:9570574pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9570574pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:9570574pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:735entrezgene:pubmedpubmed-article:9570574lld:entrezgene